These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey. Nguyen CT, Moi ML, Le TQM, Nguyen TTT, Vu TBH, Nguyen HT, Pham TTH, Le THT, Nguyen LMH, Phu Ly MH, Ng CFS, Takemura T, Morita K, Hasebe F. BMC Infect Dis; 2020 May 11; 20(1):332. PubMed ID: 32393198 [Abstract] [Full Text] [Related]
14. Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas. Nascimento EJM, Bonaparte MI, Luo P, Vincent TS, Hu B, George JK, Áñez G, Noriega F, Zheng L, Huleatt JW. Am J Trop Med Hyg; 2019 Sep 11; 101(3):708-715. PubMed ID: 31392955 [Abstract] [Full Text] [Related]
18. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas. Montoya M, Collins M, Dejnirattisai W, Katzelnick LC, Puerta-Guardo H, Jadi R, Schildhauer S, Supasa P, Vasanawathana S, Malasit P, Mongkolsapaya J, de Silva AD, Tissera H, Balmaseda A, Screaton G, de Silva AM, Harris E. J Infect Dis; 2018 Jul 13; 218(4):536-545. PubMed ID: 29618091 [Abstract] [Full Text] [Related]
19. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections. Warnecke JM, Lattwein E, Saschenbrecker S, Stöcker W, Schlumberger W, Steinhagen K. J Virol Methods; 2019 May 13; 267():8-15. PubMed ID: 30779938 [Abstract] [Full Text] [Related]
20. Clinical and laboratory profile of Zika virus infection in dengue suspected patients: A case series. Fernanda Estofolete C, Terzian AC, Parreira R, Esteves A, Hardman L, Greque GV, Rahal P, Nogueira ML. J Clin Virol; 2016 Aug 13; 81():25-30. PubMed ID: 27289428 [Abstract] [Full Text] [Related] Page: [Next] [New Search]